Florian Willecke Selected Research

Florian Willecke Research Topics

Disease

12	Atherosclerosis 11/2021 - 04/2011
12	Inflammation (Inflammations) 10/2021 - 04/2011
6	Insulin Resistance 10/2018 - 01/2012
5	Obesity 10/2021 - 01/2012
4	Atherosclerotic Plaque (Atheroma) 11/2021 - 01/2015
4	Weight Gain 10/2021 - 01/2012
3	Hypercholesterolemia 11/2019 - 03/2016
2	Sepsis (Septicemia) 01/2018 - 01/2016
2	Peritonitis 01/2016 - 04/2011
1	Carotid Stenosis (Carotid Artery Stenosis) 12/2020
1	Infections 03/2020
1	Acute Coronary Syndrome 03/2020
1	Coronary Disease (Coronary Heart Disease) 03/2020
1	Neointima 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018
1	Necrosis 01/2018
1	Neoplasms (Cancer) 01/2018
1	Bacteremia 01/2018
1	Cytokine Release Syndrome 01/2018
1	Heart Failure 01/2016
1	Hypertriglyceridemia 01/2015
1	Hyperglycemia 01/2015
1	Rupture 01/2013
1	Myocardial Infarction 01/2013
1	Metabolic Diseases (Metabolic Disease) 01/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2012
1	Thrombosis (Thrombus) 11/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2011
1	Asthma (Bronchial Asthma) 09/2011
1	Rheumatoid Arthritis 09/2011

Drug/Important Bio-Agent (IBA)

9	CholesterolIBA 12/2020 - 01/2015
5	Insulin (Novolin)FDA Link 10/2021 - 01/2012
5	LDL Receptors (LDL Receptor)IBA 01/2018 - 09/2011
3	Apolipoproteins E (ApoE)IBA 11/2021 - 03/2016
3	LipidsIBA 12/2020 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 06/2014
3	CD40 Ligand (CD40L)IBA 01/2019 - 11/2011
2	TNF Receptor-Associated Factor 5IBA 10/2021 - 01/2019
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2021 - 01/2019
2	Factor V (Coagulation Factor V)IBA 10/2021 - 01/2019
2	Lipoproteins (Lipoprotein)IBA 12/2020 - 01/2018
2	OligonucleotidesIBA 11/2019 - 01/2018
2	Antisense OligonucleotidesIBA 11/2019 - 01/2018
2	LigandsIBA 01/2019 - 01/2018
2	Purinergic Receptors (Receptors, Purine)IBA 10/2018 - 01/2016
2	Adenosine Triphosphate (ATP)IBA 10/2018 - 01/2016
2	AdipokinesIBA 01/2018 - 01/2012
2	fostamatinibIBA 03/2016 - 09/2011
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 01/2015
2	CytokinesIBA 01/2012 - 04/2011
1	ApolipoproteinsIBA 11/2021
1	Blood Glucose (Blood Sugar)IBA 10/2021
1	Atorvastatin (Lipitor)FDA Link 12/2020
1	LDL CholesterolIBA 12/2020
1	Lipoprotein(a)IBA 03/2020
1	oxidized low density lipoproteinIBA 03/2020
1	C-Reactive ProteinIBA 03/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2020
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 03/2020
1	empagliflozinIBA 11/2019
1	CollagenIBA 11/2019
1	C-PeptideIBA 10/2018
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2018
1	Purinergic P2 Receptors (ADP Receptor)IBA 10/2018
1	ChemokinesIBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	IntegrinsIBA 01/2018
1	InflammasomesIBA 06/2017
1	Purinergic P2Y2 ReceptorsIBA 01/2016
1	PalmitatesIBA 01/2015
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	FGK45 monoclonal antibodyIBA 06/2014
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2013
1	Immunoglobulin G (IgG)IBA 01/2012
1	AntibodiesIBA 01/2012
1	Peptides (Polypeptides)IBA 11/2011
1	Syk KinaseIBA 09/2011
1	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 04/2011
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2011

Therapy/Procedure

2	Therapeutics 03/2020 - 01/2018
2	Fat-Restricted Diet (Diet, Fat Restricted) 01/2015 - 01/2012
1	Diet Therapy (Therapy, Diet) 12/2020
1	Drug Therapy (Chemotherapy) 03/2020